Inside the Surge of Venture Funding in US Life Sciences
Venture funding in the United States life sciences sector is undergoing a complex resurgence, marked less by volume expansion and more by capital concentration and strategic selectivity. After a period of contraction driven by macroeconomic tightening and regulatory uncertainty, 2025 and early 2026 data indicate a recalibrated investment landscape. Investors are re-entering the market, but … Read more